Stephens Inc. AR Sells 15,892 Shares of Oracle Corporation $ORCL

Stephens Inc. AR decreased its holdings in shares of Oracle Corporation (NYSE:ORCL) by 21.9% during the fourth quarter, HoldingsChannel reports. The fund owned 56,773 shares of the enterprise software provider’s stock after selling 15,892 shares during the quarter. Stephens Inc. AR’s holdings in Oracle were worth $11,179,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of ORCL. Xponance Inc. lifted its stake in Oracle by 1.8% in the third quarter. Xponance Inc. now owns 406,544 shares of the enterprise software provider’s stock worth $114,336,000 after purchasing an additional 7,320 shares during the last quarter. Stonegate Investment Group LLC lifted its stake in Oracle by 3.2% in the third quarter. Stonegate Investment Group LLC now owns 99,400 shares of the enterprise software provider’s stock worth $27,955,000 after purchasing an additional 3,065 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its stake in Oracle by 62.1% in the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 483,000 shares of the enterprise software provider’s stock worth $135,839,000 after purchasing an additional 184,996 shares during the last quarter. DDD Partners LLC bought a new stake in Oracle in the fourth quarter worth $1,677,000. Finally, William Blair Investment Management LLC lifted its stake in Oracle by 28.6% in the third quarter. William Blair Investment Management LLC now owns 1,107,586 shares of the enterprise software provider’s stock worth $311,497,000 after purchasing an additional 246,243 shares during the last quarter. Institutional investors own 42.44% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on ORCL. Scotiabank lowered their price target on shares of Oracle from $220.00 to $215.00 and set a “sector outperform” rating for the company in a research note on Monday, March 9th. Oppenheimer boosted their price target on shares of Oracle from $210.00 to $235.00 and gave the stock an “outperform” rating in a research note on Tuesday. TD Cowen lowered their price objective on shares of Oracle from $350.00 to $250.00 and set a “buy” rating for the company in a research note on Friday, March 6th. Jefferies Financial Group lowered their price objective on shares of Oracle from $400.00 to $320.00 and set a “buy” rating for the company in a research note on Thursday, March 5th. Finally, DA Davidson upped their price objective on shares of Oracle from $180.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, March 11th. Three analysts have rated the stock with a Strong Buy rating, twenty-nine have issued a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Oracle presently has a consensus rating of “Moderate Buy” and an average price target of $261.46.

Oracle Price Performance

ORCL stock opened at $193.13 on Friday. Oracle Corporation has a 1 year low of $134.57 and a 1 year high of $345.72. The company has a market cap of $555.44 billion, a P/E ratio of 34.67, a PEG ratio of 1.84 and a beta of 1.55. The firm has a 50-day moving average of $162.96 and a 200 day moving average of $182.92. The company has a debt-to-equity ratio of 3.66, a current ratio of 1.35 and a quick ratio of 1.35.

Oracle (NYSE:ORCL) last released its quarterly earnings results on Tuesday, March 10th. The enterprise software provider reported $1.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.08. The company had revenue of $17.19 billion during the quarter, compared to the consensus estimate of $16.91 billion. Oracle had a net margin of 25.30% and a return on equity of 62.70%. Oracle’s revenue was up 21.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.47 earnings per share. Oracle has set its Q4 2026 guidance at 1.960-2.000 EPS. On average, sell-side analysts forecast that Oracle Corporation will post 6.08 EPS for the current year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 24th. Shareholders of record on Thursday, April 9th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Thursday, April 9th. Oracle’s dividend payout ratio is 35.91%.

Insiders Place Their Bets

In other Oracle news, EVP Stuart Levey sold 15,000 shares of the company’s stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $176.19, for a total value of $2,642,850.00. Following the sale, the executive vice president owned 3,429 shares in the company, valued at approximately $604,155.51. This represents a 81.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 40.90% of the company’s stock.

Key Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: 24/7 Wall St. reiterated a bullish view on Oracle (ORCL), setting a 12-month price target of about $245 and pointing to strong backlog growth and accelerating cloud infrastructure economics as key upside drivers.
• Positive Sentiment: Wedbush said Oracle is building a durable position for the next phase of the AI cycle, suggesting the market may be underestimating its role in future AI demand.
• Positive Sentiment: Coverage focused on Oracle’s “AI heavyweight” status as investors increasingly view its legacy software base, cloud expansion, and AI infrastructure exposure as a major advantage. Oracle Went From Tech Dinosaur to AI Heavyweight
• Positive Sentiment: Oracle also drew attention for expanding its agentic AI push through U.S. defense partnerships, reinforcing the idea that its AI platform is gaining traction in high-value government and enterprise use cases. Oracle Expands Its Agentic AI Push Through U.S. Defense Partnerships
• Neutral Sentiment: Oracle added Cleveland Clinic CEO Tomislav Mihaljevic to its board, which may support its healthcare strategy but is unlikely to be an immediate stock-moving catalyst. Oracle adds Cleveland Clinic CEO to board of directors

Oracle Company Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.